S14-009 CK2 inhibitors for treating medulloblastoma Researchers in Prof. Matthew Scott's laboratory have discovered that small-molecule inhibitors of casein kinase II (CK2) could be used as a targeted therapy for pediatric medulloblastoma or other Shh/hedgehog-related tumors. Teresa Purzner Matthew Scott